Phase 2b and 3 are both clinical trials. EAP is not. Phase 2b results should be uploaded (eventually). My guess would be that they are still waiting for the peer review to be completed before they do that, which should be due before the end of the year.
- Forums
- ASX - By Stock
- Paradigm Biopharmaceuticals - My Analysis, Not Mine
Phase 2b and 3 are both clinical trials. EAP is not. Phase 2b...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $97.94M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 28.0¢ | $40.10K | 140.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 135929 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 20969 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 135929 | 0.280 |
1 | 22475 | 0.275 |
7 | 102859 | 0.270 |
2 | 384000 | 0.265 |
4 | 21233 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 20969 | 2 |
0.290 | 72464 | 1 |
0.300 | 3984 | 2 |
0.305 | 55100 | 3 |
0.310 | 22870 | 4 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |